A detailed history of State Street Corp transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 188,721 shares of ACRS stock, worth $545,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
188,721
Previous 196,621 4.02%
Holding current value
$545,403
Previous $216,000 1.39%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.12 - $1.4 $8,848 - $11,060
-7,900 Reduced 4.02%
188,721 $213,000
Q2 2024

Aug 14, 2024

SELL
$1.01 - $1.36 $1.15 Million - $1.55 Million
-1,141,818 Reduced 85.31%
196,621 $216,000
Q1 2024

May 15, 2024

SELL
$0.92 - $1.44 $46,000 - $72,000
-50,000 Reduced 3.6%
1,338,439 $1.66 Million
Q4 2023

Feb 14, 2024

SELL
$0.64 - $6.49 $111,404 - $1.13 Million
-174,069 Reduced 11.14%
1,388,439 $1.46 Million
Q3 2023

Nov 14, 2023

BUY
$6.56 - $10.95 $725,037 - $1.21 Million
110,524 Added 7.61%
1,562,508 $10.7 Million
Q2 2023

Aug 14, 2023

BUY
$7.89 - $10.64 $225,890 - $304,623
28,630 Added 2.01%
1,451,984 $15.1 Million
Q1 2023

May 15, 2023

BUY
$7.07 - $17.95 $848,569 - $2.15 Million
120,024 Added 9.21%
1,423,354 $11.5 Million
Q4 2022

Feb 14, 2023

BUY
$14.33 - $18.37 $4,341 - $5,566
303 Added 0.02%
1,303,330 $20.5 Million
Q3 2022

Nov 15, 2022

BUY
$13.07 - $18.22 $951,313 - $1.33 Million
72,786 Added 5.92%
1,303,027 $20.5 Million
Q2 2022

Aug 15, 2022

BUY
$10.16 - $17.08 $1.49 Million - $2.51 Million
146,851 Added 13.55%
1,230,241 $17.2 Million
Q1 2022

May 16, 2022

BUY
$9.74 - $17.92 $350,640 - $645,120
36,000 Added 3.44%
1,083,390 $18.7 Million
Q4 2021

Feb 14, 2022

SELL
$12.27 - $18.49 $132,196 - $199,211
-10,774 Reduced 1.02%
1,047,390 $15.2 Million
Q3 2021

Nov 15, 2021

SELL
$13.38 - $18.8 $161,229 - $226,540
-12,050 Reduced 1.13%
1,058,164 $19 Million
Q2 2021

Aug 16, 2021

BUY
$17.08 - $29.6 $15 Million - $26 Million
877,272 Added 454.68%
1,070,214 $18.8 Million
Q1 2021

May 17, 2021

BUY
$5.86 - $27.73 $673,325 - $3.19 Million
114,902 Added 147.23%
192,942 $4.86 Million
Q2 2020

Aug 14, 2020

SELL
$1.04 - $1.73 $612,713 - $1.02 Million
-589,148 Reduced 88.3%
78,040 $126,000
Q1 2020

May 11, 2020

BUY
$0.75 - $2.18 $500,391 - $1.45 Million
667,188 New
667,188 $694,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $193M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.